Home > Boards > US Listed > Biotechs >

Iterum Therapeutics (itrm)

itrm RSS Feed
Add ITRM Price Alert      Hide Sticky   Hide Intro
Moderator: ADVFN_bioking
Search This Board: 
Last Post: 10/28/2019 12:43:06 PM - Followers: 0 - Board type: Free - Posts Today: 0

Market cap $51 M --Cash $52 M --3x Phase 3 readouts (potential Blockbuster) are imminent (during this quarter) ..Completely undiscovered ultra low float gem with significant upside potential could hit $10 very quickly on good results .GL


Iterum (ITRM)

Marktkap $51 M
Cash: $52 M
Price: $3.53

Shares Out 14.4 M


“The second quarter was marked by continued progress in our three pivotal Phase 3 clinical trials of sulopenem,” said Corey Fishman, Chief Executive Officer of Iterum Therapeutics plc. “Based on current enrollment rates, we anticipate topline data from the complicated intra-abdominal (cIAI) and the complicated urinary tract infection (cUTI) trials in the fourth quarter. This would allow us the flexibility to file our new drug applications (NDAs) in the first quarter of 2020."


take a look what insiders paid for their shares

http://openinsider.com/search?q=itrm


New Presentation
https://d1io3yog0oux5.cloudfront.net/_58e775e7143282a7caa480cfb5ae0c01/iterumtx/db/346/2669/pdf/Iterum+Company+Deck_October+2019.pdf


major shareholders:

Canaan Partners ...1.7M
Sofinnova ...1.7M
Frazier ...1.5M
New Leaf Venture ...1.5M
Arix Bioscience ...1.1M
Pivotal ...945.1K
Malik (Shahzad) ...868.2K
Advent Venture ...868.2K
Cormorant Asset ...396.4K
Franklin ...351.6K







itrm
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
itrm News: Iterum Therapeutics Announces Completion of Enrollment in Phase 3 Clinical Trial of Oral and IV Sulopenem in Complicated Urin... 11/18/2019 07:30:00 AM
itrm News: Quarterly Report (10-q) 11/12/2019 05:04:08 PM
itrm News: Current Report Filing (8-k) 11/12/2019 04:47:13 PM
itrm News: Iterum Therapeutics Reports Third Quarter 2019 Financial Results and Highlights 11/12/2019 04:30:00 PM
itrm News: Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2019 10/01/2019 10:07:00 AM
PostSubject
#5   LOAD UP before phase 3 results hit the wire ADVFN_bioking 10/28/19 12:43:06 PM
#4   strong buy ADVFN_bioking 10/25/19 01:25:02 PM
#3   lots of big milestones imminent ADVFN_bioking 10/24/19 03:55:05 PM
#2   UNDISCOVERED stock with brutally upside potential here ADVFN_bioking 10/24/19 11:03:56 AM
#1   next MONSTER PLAY is here ADVFN_bioking 10/23/19 03:24:08 PM
PostSubject